Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

	Year ended December 31,
	2024						2023
	GeneDx		Other		Total		GeneDx		Other		Total
Revenue	$	302,293	$	3,157	$	305,450	$	194,376	$	8,190	$	202,566
Adjusted cost of services	106,376		145		106,521		106,983		2,305		109,288
Adjusted gross profit (1)	195,917		3,012		198,929		87,393		5,885		93,278
Reconciliations:
Depreciation and amortization					4,047						4,350
Stock-based compensation					431						(1,217)
Restructuring charges					54						139
Gross profit					$	194,397					$	90,006

(1)Adjusted cost of services and adjusted gross profit exclude depreciation and amortization expense, stock-based compensation expense and restructuring costs.